Abstract
Emerging evidences have demonstrated the differential expression of LncRNA DILC in various malignancies. Nevertheless, its impact on tumor microenvironment (TME) remain limited in breast cancer. This study investigates the expression of DILC in tumor associated macrophages (TAMs) and CD8+ cells in triple negative breast cancer (TNBC) and its impact on TNF-α release that could promote breast cancer progression and drug resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
